No abstract

Atrial fibrillation is the most commonly treated arrhythmia and its incidence is predicted to increase. It is associated with significant morbidity and mortality. Preventive efforts should be initiated early and include diversified interventions to correct predisposing factors and modify the altered atrial substrate.

AF is very frequent in patients with multiple myeloma when they receive ASCT. The presence of abnormal renal function, left ventricular systolic dysfunction, dilated left atrium, or hypertension at baseline identifies patients at high risk of developing AF following ASCT.

Aims:To compare patients with atrial flutter (AFl) 220/min. (PACE 2009; 32:82-90) atrial flutter, AV conduction, ICD; syncope, tachycardia